INSM Competitors & Alternatives
Compare Insmed Inc with similar stocks in the same industry
Biotechnology
INSM
Main Stock$108.59
Tradestie Score
58
Market Cap
$31.13B
Revenue Growth
3.0%
Analyst Upside
+82.1%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.77
|
$36.81B | 65.5 | 52 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.85
|
$24.57B | - | 54 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$408.47
|
$22.18B | - | 31 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.55
|
$19.56B | 28.1 | 42 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.14
|
$16.93B | 15.2 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.63
|
$15.70B | 31.4 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.31
|
$12.36B | 17.9 | 69 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.50
|
$10.76B | - | 50 | Compare |
More INSM Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry